The Food and Drug Administration and Centers for Medicare and Medicaid Services will launch a pilot program to conduct parallel reviews of medical devices deemed innovative.

The goal is to reduce the time between FDA approval and a Medicare national coverage determination of whether it will reimburse for use of an approved device.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access